N4 Pharma (N4P)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.83p
   
  • Change Today:
      0.025p
  • 52 Week High: 3.07
  • 52 Week Low: 0.75
  • Currency: UK Pounds
  • Shares Issued: 268.78m
  • Volume: 11,074
  • Market Cap: £2.22m

Deal with Barclays    Trade now with Barclays Stockbrokers

MX Oil raises £2.5m ahead of Nigeria deal

By Josh White

Date: Monday 14 Mar 2016

LONDON (ShareCast) - (ShareCast News) - MX Oil shored up its available funds as it prepared for a quick-turnaround transaction in Nigeria on Monday, announcing the successful raising of £2.5m via a placing of 333,333,333 ordinary shares and 66,666,667 warrants over ordinary shares.
The AIM-traded oil and gas investing company said the placing was oversubscribed, and the proceeds would be used to make the final payment in connection to its investment in Nigeria prior to the start of oil production.

It was previously announced that the first payment due from GEC Petroleum Development Company with regard to its proposed purchase of MX Oil's Nigerian investment was expected around 14 March.

"We felt that it made sense to avoid any timing risk with regard to the funding of our Nigerian investment prior to it commencing production by ensuring that we had our own funds in place in order to make this payment," said MX Oil chief executive officer Stefan Oliver.

"We will update the market shortly with regard to the funds expected from GPDC and also on the progress being made in Mexico," he added.

Application was yet to be made for the placing shares to be admitted to AIM, but the company said it was expected that admission would become effective on or around 18 March. The placing shares would rank pari passu with the existing ordinary shares.

Another AIM-traded company, Onzima Ventures, announced it had participated in the placing, subscribing for 20 million shares at 0.75p per share for a total sum of £150,000. It had also received four million warrants exercisable at 1p per share, for a period of three years.

At the same time, MX Oil revealed it was discussing the possibility of assigning three of its four Mexican interests to its joint venture partner, Geo Estratos, in return for an increased interest in one licence, Tecolutla, and a cash payment to the company.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

N4 Pharma Market Data

Currency UK Pounds
Share Price 0.83p
Change Today 0.025p
% Change 3.13 %
52 Week High 3.07
52 Week Low 0.75
Volume 11,074
Shares Issued 268.78m
Market Cap £2.22m

N4 Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
34.78% below the market average34.78% below the market average34.78% below the market average34.78% below the market average34.78% below the market average
49.02% below the sector average49.02% below the sector average49.02% below the sector average49.02% below the sector average49.02% below the sector average
Value
34.78% below the market average34.78% below the market average34.78% below the market average34.78% below the market average34.78% below the market average
49.02% below the sector average49.02% below the sector average49.02% below the sector average49.02% below the sector average49.02% below the sector average
Income Not Available
Growth Not Available

N4 Pharma Dividends

No dividends found

Trades for 03-May-2024

Time Volume / Share Price
11:16 9,281 @ 0.76p
10:20 393 @ 0.75p
10:16 1,400 @ 0.76p

N4 Pharma Key Personnel

CEO Nigel Theobald

Top of Page